Cargando…
Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A
Mitofusin (MFN) 1 and MFN2 are dynamin GTPase family mitochondrial proteins that mediate mitochondrial fusion requiring MFN conformational shifts, formation of macromolecular complexes on and between mitochondria, and GTP hydrolysis. Damaging MFN2 mutations cause an untreatable, largely pediatric pr...
Autores principales: | Franco, Antonietta, Dang, Xiawei, Zhang, Lihong, Molinoff, Perry B., Dorn, Gerald W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553116/ https://www.ncbi.nlm.nih.gov/pubmed/36507849 http://dx.doi.org/10.1124/jpet.122.001332 |
Ejemplares similares
-
Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A
por: Franco, Antonietta, et al.
Publicado: (2020) -
Molecular modelling of mitofusin 2 for a prediction for Charcot-Marie-Tooth 2A clinical severity
por: Beręsewicz, Małgorzata, et al.
Publicado: (2018) -
Reciprocal Regulation of Mitofusin 2-Mediated Mitophagy and Mitochondrial Fusion by Different PINK1 Phosphorylation Events
por: Li, Jiajia, et al.
Publicado: (2022) -
Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2)
por: Engelfried, Kathrin, et al.
Publicado: (2006) -
Anesthetic management in Charcot-Marie-Tooth disease type 2 due to a mutation in the mitofusin-2 gene
por: Vinci, Paolo, et al.
Publicado: (2011)